Fecal microbiota transplantation in treating Clostridium difficile infection

Journal of Digestive Diseases

Volumn 15, Issue 8, 2014, Pages 405-408

  Brown, William R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Dysbiosis; Fecal enema; Fecal microbiota transplantation; Pseudomembranous enterocolitis

Indexed keywords

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SAFETY; TREATMENT OUTCOME; ADVERSE EFFECTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; MICROBIOLOGY; MICROFLORA; PATIENT ATTITUDE; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; TISSUE TRANSPLANTATION; TRENDS;

CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; MICROBIOTA; PATIENT ACCEPTANCE OF HEALTH CARE; TISSUE TRANSPLANTATION;

EID: 84904858663     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12160     Document Type: Article

References (31)

1. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-339.
2. Pathak R, Enuh HA, Patel A, Wickremesinghe P. Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation. Clin Exp Gastroenterol 2013; 7: 1-6.
3. Mattila E, Uusitalo-Seppälä R, Wuorela M etal. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-496.
4. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999; 20: 43-50.
5. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1, 700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1755; author reply 1755-6.
6. Eiseman B, Silen W, Bascon GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859.
7. Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983; 2: 845.
8. Brandt LJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013; 108: 177-185.
9. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
10. Lawley TD, Clare S, Walker AW etal. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. Plos Pathog 2012; 8: e1002995.
11. Song Y, Garg S, Girotra M etal. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS ONE 2013; 8: e81330.
12. Dutta SK, Girotra M, Garg S etal. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2014; pii: S1542-3565(14)00048-2 [Epub ahead of print].
13. Lee CH, Belanger JE, Kassam Z etal. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis 2014; 33: 1425-1428.
14. Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012; 40: 643-648.
15. Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014; 68: 363-368.
16. Brandt LJ, Aroniadis OC, Mellow M etal. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 1079-1087.
17. Friedman-Moraco RJ, Mehta AK, Lyon GM, Kraft CS. Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients. Am J Transplant 2014; 14: 477-480.
18. Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. Am J Med 2014; 127: 479-483.
19. Broecker F, Kube M, Klumpp J etal. Analysis of the intestinal microbiome of a recovered Clostridium difficile patient after fecal transplantation. Digestion 2013; 88: 243-251.
20. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 2014; [Epub ahead of print].
21. Di Bella S, Drapeau C, García-Almodóvar E, Petrosillo N. Fecal microbiota transplantation: the state of the art. Infect Dis Rep 2013; 5: e13.
22. Moore T, Rodriguez A, Bakken JS. Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin Infect Dis 2014; 58: 541-545.
23. FDA. Guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. 2013 July 18. Cited 20 May 2014. Available from URL: http://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/vaccines/ucm361379.htm.
24. Borody TJ, Peattie D, Kapur A. Could fecal microbiota transplantation cure all Clostridium difficile infections? Future Microbiol 2014; 9: 1-3.
25. Lofgren ET, Moehring RW, Anderson DJ, Weber DJ, Fefferman NH. A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol 2014; 35: 18-27.
26. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011; 9: 88-96.
27. Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc 2014; 89: 107-114.
28. Pamer EG. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol 2014; 7: 210-214.
29. Petrof EO, Gloor GB, Vanner SJ etal. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013; 1: 3.
30. Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology 2014; 146: 1573-1582.
31. Rineh A, Kelso MJ, Vatansever F, Tegos GP, Hamblin MR. Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther 2014; 12: 131-150.